Skip to main content

Johnston John Joseph's Form 4 filing

Maxcyte, Inc. (MXCT) · filed Jun 28, 2023

Accession no.
0001209191-23-040058
Filed
Jun 28, 2023
Trade date
Jun 26-27, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $66.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Johnston John JosephCIK 0001874850Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 26, 2023Common StockMOption exerciseAcquired+6,817$0.98+$6,680.66127,400Direct
Jun 26, 2023Common StockMOption exerciseAcquired+712$1.64+$1,167.68128,112Direct
Jun 26, 2023Common StockSSaleDisposed−7,529$4.49−$33,805.21120,583Direct
Jun 27, 2023Common StockMOption exerciseAcquired+7,471$1.64+$12,252.44128,054Direct
Jun 27, 2023Common StockSSaleDisposed−7,471$4.39−$32,797.69120,583Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 26, 2023Common StockMOption exerciseDisposed−6,817$0.00$00Direct
Jun 26, 2023Common StockMOption exerciseDisposed−712$0.00$026,188Direct
Jun 27, 2023Common StockMOption exerciseDisposed−7,471$0.00$018,717Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)